Assessment of the prevalence of H1N1 in Brazil between 2016 and 2020 and the importance of vaccination as a strategy to reduce cases
DOI:
https://doi.org/10.33448/rsd-v11i13.35409Keywords:
H1N1; Vaccine; Necessity; Contagion reduction.Abstract
In April 2009, there was an outbreak of illness caused by the novel influenza A(H1N1) virus, which has a rapid power of dissemination. Initially it was known as “swine flu”, due to the genetic event that caused the emergence of the new pandemic subtype resulting from the genetic recombination of swine, avian and human viruses, having a high potential for spread among humans. In this way, the present study is based on the construction of an integrative bibliographical review, using the PRISMA-type methodology, aiming at evaluating the prevalence of influenza A(H1N1) in Brazil between 2016 and 2020 and the impact of vaccination as a strategy to reduce the two cases. The study eligibility criteria for this research will result in 11 studies relevant to the discussion process. Desses, representatively, 1 from Scielo, 3 from Pubmed and 7 from Sciencedirect. As it was possible to identify that influenza A/H1N1 is an acute infectious disease with high morbidity and mortality, with these prevalent rates in patients, children, pregnant women and carriers of chronic diseases. However, it was found that vaccination was effective in preventing the evolution of disease for its most severe form, and the development of new pathologies, as well as avoiding hospitalizations, as well as medical expenses.
References
Arriola, C. S., El Omeiri, N., Azziz-Baumgartner, E., Thompson, M. G., Sotomayor-Proschle, V., Fasce, R. A., & Pinzón, C. (2019). Influenza vaccine effectiveness against hospitalizations in children and older adults—Data from South America, 2013–2017. A test negative design. Vaccine: X, 3, 100047.
Bellei, N., & Melchior, T. B. (2011). H1N1: pandemia e perspectiva atual. Jornal Brasileiro de Patologia e Medicina Laboratorial, 47, 611-617.
Biondo, G. F., Santana, J. C., Lago, P. M., Piva, J., Souza, P. R. A., Gaulke, J. G., & Sebben, J. M. (2018). Impact of A/H1N1 influenza in children at a Brazilian University Hospital. Brazilian Journal of Infectious Diseases, 22, 219-223.
Brasil. (2013). Influenza: Monitoramento até a Semana Epidemiológica 52, de 2013. Boletim Epidemiológico, 44(15).
Cardoso, A. M., Resende, P. C., Paixao, E. S., Tavares, F. G., Farias, Y. N., Barreto, C. T. G., & Siqueira, M. M. (2019). Investigation of an outbreak of acute respiratory disease in an indigenous village in Brazil: Contribution of Influenza A (H1N1) pdm09 and human respiratory syncytial viruses. PLoS One, 14(7), e0218925.
Chaves, K. C. B., Duarte, A. S., Bernardo, A. B. S., da Silveira, F. R., Teixeira, C. S., & da Costa Júnior, G. E. (2017). TRANSMISSIBILIDADE DOMICILIAR-ABORDAGEM CLÍNICA DO VÍRUS INFLUENZA. In Anais Colóquio Estadual de Pesquisa Multidisciplinar (ISSN-2527-2500) & Congresso Nacional de Pesquisa Multidisciplinar.
Felinto, G. M., Escosteguy, C. C., & Medronho, R. D. A. (2018). Fatores associados ao óbito dos casos graves de influenza A (H1N1) pdm09. Cadernos Saúde Coletiva, 27, 11-19.
Fiocruz, 2022. https://www.gov.br/pt-br/servicos/vacinar-contra-h1n1
Hennessy, T. W., Bruden, D., Castrodale, L., Komatsu, K., Erhart, L. M., Thompson, D., & Landen, M. (2016). A case-control study of risk factors for death from 2009 pandemic influenza A (H1N1): is American Indian racial status an independent risk factor?. Epidemiology & Infection, 144(2), 315-324.
Jaldin, A. E. M., Nogueira, L. M., Junior, N. D. J. P. B., Marques, C. P. C., Costa, I. S., Campos, J. R. N., & de Souza Costa, S. (2021). Análise dos casos de gripe A (H1N1) no Brasil e no estado do Maranhão de 2009 a 2019. Research, Society and Development, 10(12), e453101219318-e453101219318.
Lobo, R. D. (2015). Fatores de risco para aquisição de influenza A (H1N1) pdm09 entre os profissionais de saúde (Doctoral dissertation, Universidade de São Paulo).
Machado, A. A. (2009). Infecção pelo vírus Influenza A (H1N1) de origem suína: como reconhecer, diagnosticar e prevenir. Jornal Brasileiro de Pneumologia, 35, 464-469.
Machado, C. M., de Souza, A. C. M. F., Romano, C. M., dos Santos Freire, W., Costa, Â. A., Figueiredo, W. M., & Luna, E. J. (2020). Influenza A and B in a cohort of outpatient children and adolescent with influenza like-illness during two consecutive influenza seasons. Brazilian Journal of Infectious Diseases, 24, 73-80.
Palkonyay, L., & Fatima, H. (2016). A decade of adaptation: Regulatory contributions of the World Health Organization to the Global Action Plan for Influenza Vaccines (2006–2016). Vaccine, 34(45), 5414-5419.
Pfitscher, L. C., Cecatti, J. G., Pacagnella, R. C., Haddad, S. M., Parpinelli, M. A., Souza, J. P., & Costa, M. L. (2016). Severe maternal morbidity due to respiratory disease and impact of 2009 H1N1 influenza A pandemic in Brazil: results from a national multicenter cross-sectional study. BMC Infectious Diseases, 16(1), 1-10.
Portal Brasil (2022). Anvisa define nova composição da vacina contra gripe para 2017, 2016. <http://www.brasil.gov.br/saude/2016/10/anvisa-define-nova-composicao-da-vacina-contra-gripe-para-2017>.
Privor-Dumm, L., Vasudevan, P., Kobayashi, K., & Gupta, J. (2020). Archetype analysis of older adult immunization decision-making and implementation in 34 countries. Vaccine, 38(26), 4170-4182..
Puig-Barberà, J., Burtseva, E., Yu, H., Cowling, B. J., Badur, S., Kyncl, J., & Sominina, A. (2016). Influenza epidemiology and influenza vaccine effectiveness during the 2014–2015 season: annual report from the Global Influenza Hospital Surveillance Network.
Respiratória, T. (2009). Características dos casos notificados de Influenza A/H1N1. Rev Saúde Pública, 43(5), 900-4.
Ribeiro, I. G., & Sanchez, M. N. (2020). Avaliação do sistema de vigilância da síndrome respiratória aguda grave (SRAG) com ênfase em influenza, no Brasil, 2014 a 2016. Epidemiologia e Serviços de Saúde, 29.
Santos, K. C. D. O., Silva, D. B. B. D., Sasaki, N. A., Benega, M. A., Garten, R., & Paiva, T. M. D. (2017). Molecular epidemiology of influenza A (H1N1) PDM09 hemagglutinin gene circulating in Sao Paulo State, Brazil: 2016 anticipated influenza season. Revista do Instituto de Medicina Tropical de São Paulo, 59.
Sato, A. P. S., Antunes, J. L. F., Lima-Costa, M. F. F., & de Andrade, F. B. (2020). Influenza vaccine uptake among older adults in Brazil: socioeconomic equality and the role of preventive policies and public services. Journal of Infection and Public Health, 13(2), 211-215.
Secretaria de Vigilância em Saúde. (2010). Influenza pandêmica (H1N1) 2009 análise da situação epidemiológica e da resposta no ano de 2009. Boletim Eletrônico Epidemiológico, 10(1), 1-21.
Senna, M. C., Cruz, V. D., Pereira, A. C. G., Maciel, R. L., Borges, Á., Melo, C., & Pedroso, E. R. P. (2009). Emergência do vírus influenza A-H1N1 no Brasil: a propósito do primeiro caso humano em Minas Gerais. Rev Med Minas Gerais, 19(2), 173-176.
Souza, E. P. D., & Teixeira, M. D. S. (2012). Pandemic influenza A/H1N1 vaccination coverage, adverse reactions, and reasons for vaccine refusal among medical students in Brazil. Revista do Instituto de Medicina Tropical de São Paulo, 54, 77-82.
Temporão, J. G. (2009). O enfrentamento do Brasil diante do risco de uma pandemia de influenza pelo vírus A (H1N1). Epidemiologia e Serviços de Saúde, 18(3), 201-204.
Troeger, C. E., Blacker, B. F., Khalil, I. A., Zimsen, S. R., Albertson, S. B., Abate, D., & Rai, R. K. (2019). Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. The Lancet Respiratory Medicine, 7(1), 69-89.
Ventura, C. G., Roque, F. L., Sousa, I. Q. D., Lobo, R. D., & Luders, C. (2020). Influenza A (H1N1): outbreak management in a dialysis unit and clinical outcomes of infection in chronic hemodialysis patients. Brazilian Journal of Nephrology, 42, 182-190.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Luana Rigo Gomes; Diego Antônio Cavalcante de Araujo ; Thadeu Demski Neto; Luan Felipo Botelho Souza
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
